Analysen von Florent Cespedes

23.03.17 Roche buy Société Générale Group S.A. (SG)
23.03.17 Sanofi buy Société Générale Group S.A. (SG)
08.03.17 Novartis buy Société Générale Group S.A. (SG)
31.10.16 Sanofi buy Société Générale Group S.A. (SG)
01.08.16 Sanofi buy Société Générale Group S.A. (SG)
06.04.16 Sanofi buy Société Générale Group S.A. (SG)
10.02.16 Sanofi buy Société Générale Group S.A. (SG)
09.11.15 Sanofi buy Société Générale Group S.A. (SG)
30.10.15 Sanofi buy Société Générale Group S.A. (SG)
03.07.15 Sanofi buy Société Générale Group S.A. (SG)
16.04.15 Sanofi buy Société Générale Group S.A. (SG)
19.09.14 Bayer Outperform BNP PARIBAS
04.09.14 Sanofi Outperform BNP PARIBAS
04.09.14 Novartis Outperform BNP PARIBAS
01.08.14 Sanofi Outperform BNP PARIBAS
27.05.14 Novartis Outperform BNP PARIBAS
02.05.14 Bayer Outperform BNP PARIBAS
17.03.14 Bayer Outperform BNP PARIBAS
24.08.12 GSK outperform Exane-BNP Paribas SA
03.08.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
02.08.12 Shire outperform Exane-BNP Paribas SA
27.07.12 Sanofi outperform Exane-BNP Paribas SA
27.07.12 Roche outperform Exane-BNP Paribas SA
26.07.12 GSK outperform Exane-BNP Paribas SA
19.07.12 GSK outperform Exane-BNP Paribas SA
18.07.12 Shire outperform Exane-BNP Paribas SA
16.07.12 Actelion outperform Exane-BNP Paribas SA
26.06.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
26.06.12 Shire outperform Exane-BNP Paribas SA
19.06.12 GSK outperform Exane-BNP Paribas SA
04.05.12 Teva Pharmaceutical Industries outperform Exane-BNP Paribas SA
30.04.12 Sanofi outperform Exane-BNP Paribas SA
24.04.12 Sanofi outperform Exane-BNP Paribas SA
02.04.12 GSK outperform Exane-BNP Paribas SA
16.03.12 Roche outperform Exane-BNP Paribas SA
03.09.10 Bayer outperform Exane-BNP Paribas SA